Company Overview

Facts & Figures that Define Us

1st
Saudi biomedical company focused exclusively on camel-based innovation
0%
Ethically sourced materials in compliance with animal welfare standards
+0
Active research projects in camel-based biotechnology
Contributing to Saudi Vision 2030 through localization of biotech solutions

Overview of CamelX as a Saudi biotech company aligned with Vision 2030.

Aligned with the goals of Vision 2030 and the National Biotechnology Strategy, CamelX is committed to localizing biopharma, empowering national talent, and transforming indigenous knowledge into globally relevant solutions. By harnessing the unique biology of camels, we aim to advance therapeutic innovation, strengthen healthcare independence, and position Saudi Arabia as a global leader in sustainable biotech.

The Camel Knowledge Hub: Expert Insights & Breakthroughs.

Stay informed on CamelX's thought leadership, breakthroughs, and industry insights. Access articles authored by our expert team to discover how camels are driving innovation, sustainability, and biosecurity in Saudi Arabia.

August 2024

Concept Conceived

The idea for CamelX was first envisioned, aiming to transform camel biology into a foundation for medical innovation.

Concept Conceived Icon
December 2024

Scientific Breakthrough

On December 18, 2024, our team reached a major scientific milestone by identifying a highly stable and promising compound for targeted therapeutic development.

Scientific Breakthrough Icon
March 2025

CamelX Officially Launched

CamelX officially launched as a biotech company, backed by $5 million in seed funding, with a bold mission to pioneer camel-derived medical solutions.

CamelX Officially Launched Icon
March 2025

Global Partnership Signed

On March 18, 2025, CamelX signed a strategic partnership with a leading global pharmaceutical company to co-develop and commercialize camel-derived therapeutics.

Global Partnership Signed Icon
June 2025

First Patent Filed

On June 1, 2025, CamelX began the filing process for its first patent in collaboration with one of the leading law firms in the United States, marking a major step in protecting our proprietary biotechnology platform.

First Patent Filed Icon
June 2025

National Partnership Signed

On June 2, 2025, CamelX entered a strategic collaboration with one of Saudi Arabia's top pharmaceutical leaders to accelerate the development and localization of camel-based biologics.

National Partnership Signed Icon

What's Next for CamelX?

Our innovation journey continues as we expand our research into new therapeutic areas and advance our existing pipeline toward clinical trials. Stay tuned for our next breakthrough.